INTEGRA LIFESCIENCES HOLDINGS CORP Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent of 0.00% for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2022-02-24
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2021 was 0.00%.
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2020 was 0.00%, a 100.00% decline from fiscal 2019.
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2019 was 22.70%.
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2018 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month |
|---|---|
| 2021-12-31 | 0.00% 10-K · filed 2022-02-24 |
| 2020-12-31 | 0.00% 10-K · filed 2022-02-24 |
| 2019-12-31 | 22.70% 10-K · filed 2022-02-24 |
| 2018-12-31 | 0.00% 10-K · filed 2021-02-23 |
| 2017-12-31 | 0.00% 10-K · filed 2020-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |